Pharm'Up 
A groundbreaking study published in the Journal of Proteome Research has challenged the long-held assumption that children are largely immune to the serious, long-term health consequences of COVID-19. Researchers from Harvard and Murdoch University have identified significant metabolic disruptions in children who have had SARS-CoV-2 infections, with a particularly marked impact on those who developed Multisystem Inflammatory Syndrome in Children (MIS-C). These metabolic shifts are closely associated with established risk factors for cardiovascular disease, raising serious concerns about future health complications.
While children generally experience milder respiratory symptoms from COVID-19 compared to adults, they are uniquely susceptible to MIS-C, a rare but severe hyperinflammatory syndrome that typically emerges weeks after an initial infection. Previous research had already linked MIS-C to short-term complications and long-term issues, including severe gastrointestinal symptoms and cardiovascular injury. This new study provides crucial molecular evidence of these long-term risks.
Deep Metabolic Profiling Reveals Concerning Patterns
The investigators conducted the largest-ever metabolic profiling study on children following SARS-CoV-2 infection, analyzing blood samples from 147 children across three groups: those with acute COVID-19, those with MIS-C, and a healthy control group. By performing deep metabolic phenotyping on over 1,100 metabolites, they found that both the COVID-19 and MIS-C cohorts exhibited distinct metabolic profiles compared to the healthy children.
A central finding was the significant shifts in lipid classes—fats in the blood—that are directly tied to cardiovascular health. The study revealed consistent increases in the Apo-B100/Apo-A1 ratio, a well-known predictive marker for atherosclerosis and future heart disease. Additionally, the researchers observed elevated triglycerides and changes in both high-density lipoprotein (HDL) and low-density lipoprotein (LDL) parameters in the infected children.
A Molecular Bridge Between Pediatric and Adult Infection
Perhaps most critically, the study demonstrated a strong similarity in metabolic perturbations between children with COVID-19 and adults who have had the virus, despite the children’s milder clinical symptoms. The inflammatory markers observed in adult patients—such as altered glutamine-to-glutamate ratios and elevated systemic inflammatory biomarkers—were consistently found in the pediatric cohorts as well.
The authors concluded that while children might be better at maintaining metabolic stability during acute infection, the persistence of these inflammatory and cardiovascular markers poses a tangible risk for long-term health. The patients with MIS-C were the most severely affected, showing the most pronounced metabolic alterations. This study serves as a stark warning, highlighting a potential silent epidemic of long-term cardiovascular issues stemming from childhood COVID-19 infections. The investigators stressed the urgent need for further research to fully understand these lasting impacts and develop appropriate long-term monitoring and care strategies for affected children.
About the Author
